ALEXANDRIA, Va., April 21 -- United States Patent no. 12,605,429, issued on April 21, was assigned to UNIVERSITY OF GEORGIA RESEARCH FOUNDATION INC. (Athens, Ga.).
"Proteins having pneumococcal capsule degrading activity and methods of use" was invented by Fikri Y. Avci (Watkinsville, Ga.), Dustin Middleton (Athens, Ga.) and Amy Victoria Paschall (Washington, Ga.).
According to the abstract* released by the U.S. Patent & Trademark Office: "Provided herein is a protein, referred to as a Pn3Pase protein, that degrades the capsular polysaccharide of serotype 3 Streptococcus pneumoniae. The disclosure includes a genetically modified cell that includes a Pn3Pase protein, and compositions that include the protein, the polynucleotide encoding th...